In 2020, injectables saw improvements in consultations, combination therapy, and more.
The U.S. International Trade Commission recently announced it will uphold the ban on Jeuveau, changing its original sentence from 10 years to 21 months.
FDA approvals in 2020 included Galderma’s Restylane Kysse, Endo Aesthetics QWO for cellulite, and more.
Revance Therapeutics announces positive phase 2 DAXI results and provides an update on expected FDA Approval.
This week, consumer magazines highlight what to know before trying dermal fillers, psychedelic mushrooms for wellness, and more.
In 2020, our readers were most interested in articles covering COVID-19 reopening protocols, Iraqi female physicians marrying cosmetic surgery with a respect of tradition and more.